BIOPHYTIS SA-ADR (BPTS) Stock Price & Overview
NASDAQ:BPTS • US09076G2030
Current stock price
The current stock price of BPTS is 8.22 USD. Today BPTS is down by -15.28%. In the past month the price decreased by -41.29%. In the past year, price decreased by -94.66%.
BPTS Key Statistics
- Market Cap
- 94.203M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -7.80
- Dividend Yield
- N/A
BPTS Stock Performance
BPTS Stock Chart
BPTS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BPTS. When comparing the yearly performance of all stocks, BPTS is a bad performer in the overall market: 99.36% of all stocks are doing better.
BPTS Earnings
BPTS Forecast & Estimates
8 analysts have analysed BPTS and the average price target is 0.38 USD. This implies a price decrease of -95.36% is expected in the next year compared to the current price of 8.22.
BPTS Groups
Sector & Classification
BPTS Financial Highlights
Over the last trailing twelve months BPTS reported a non-GAAP Earnings per Share(EPS) of -7.8. The EPS increased by 63.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -134.02% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BPTS Ownership
BPTS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BPTS
Company Profile
Biophytis SA operates as a clinical-stage biotechnology company. The company is headquartered in Paris, Ile-De-France and currently employs 26 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Company Info
IPO: 2015-07-13
BIOPHYTIS SA-ADR
14 avenue de l'Opera
Paris ILE-DE-FRANCE 75252 FR
CEO: Stanislas Veillet
Employees: 26
Phone: 33141836600
BIOPHYTIS SA-ADR / BPTS FAQ
What does BPTS do?
Biophytis SA operates as a clinical-stage biotechnology company. The company is headquartered in Paris, Ile-De-France and currently employs 26 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Can you provide the latest stock price for BIOPHYTIS SA-ADR?
The current stock price of BPTS is 8.22 USD. The price decreased by -15.28% in the last trading session.
What is the dividend status of BIOPHYTIS SA-ADR?
BPTS does not pay a dividend.
What is the ChartMill rating of BIOPHYTIS SA-ADR stock?
BPTS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the market capitalization of BPTS stock?
BIOPHYTIS SA-ADR (BPTS) has a market capitalization of 94.20M USD. This makes BPTS a Micro Cap stock.
What is the ownership structure of BIOPHYTIS SA-ADR (BPTS)?
You can find the ownership structure of BIOPHYTIS SA-ADR (BPTS) on the Ownership tab.